← All migraine research topics
MigraineMind research collection

Migraine Prevention Research

Explore migraine prevention research, including preventive treatments, clinical trials, Botox and treatment strategies.

54 quality-gated research papers
  1. Real-world effectiveness and safety of eptinezumab in migraine prevention.

    Expert Opin Biol Ther | 2026

    Authors: Pellesi L, Scuteri D, Allamprese R, Guerzoni S, Martelletti P Clinical trial

    Eptinezumab is a new medication for preventing migraines. It is an intravenous treatment that targets a specific protein involved in migraine attacks. Previous studies showed it works well for both episodic and…

  2. Atogepant for the preventive treatment of high-frequency episodic migraine: Subgroup analysis from the ADVANCE and ELEVATE trials.

    Headache | 2026

    Authors: Ashina H, Carr K, Lee MJ, Nagy K, Wang YF Clinical trial

    Atogepant is a new oral medication for preventing high-frequency episodic migraines. High-frequency episodic migraine (HFEM) causes increased pain and difficulties in daily life. This research looked at how effective…

  3. Persistence of pharmacological migraine prevention based on statutory health insurance claims data from Germany: a retrospective cohort study.

    Front Health Serv | 2026

    Authors: Domdey A, Gscheidle S, Löhr H, Maier PM, Arnold M Observational study

    Migraine is a significant health issue affecting many people in Germany. About 15% of women and 6% of men suffer from migraines. These headaches cause a large loss of healthy life years. Preventive treatments aim to…

  4. Cost-effectiveness of onabotulinumtoxinA versus topiramate in chronic migraine in the US: an economic analysis of the FORWARD randomized trial.

    J Med Econ | 2026

    Authors: Ronquest N, Zhang Y, Park TJ, Campbell K, Anderson S Clinical trial

    This study compared the cost-effectiveness of two migraine treatments: OnabotA and topiramate. Researchers focused on chronic migraine patients in the US. They used a complex model to evaluate costs and benefits over…

  5. Comparative efficacy of vitamins and nutraceuticals for migraine prevention: A systematic review and network meta-analysis of randomized controlled trials.

    Headache | 2026

    Authors: Ahmed M, Aiman U, Kukreja N, Rayyan SM, Shahzad UB Systematic review / meta-analysis

    Migraine affects millions of people worldwide and can be debilitating. Traditional medications may not work well for everyone. Some patients seek alternative treatments like vitamins and nutraceuticals. This research…

  6. [Pharmacological properties and individualized selection of CGRP inhibitors for migraine prevention and acute treatment].

    Zh Nevrol Psikhiatr Im S S Korsakova | 2026

    Authors: Batrakhanova MM, Dogadailova AM, Orekhova LE, Karlov NR, Anisimov II Review

    This article reviews the use of CGRP inhibitors for migraine treatment. These include monoclonal antibodies and small-molecule receptor antagonists. Monoclonal antibodies like erenumab and fremanezumab have proven…

  7. Serum Concentration Relationships of Candesartan in Migraine Prevention.

    Basic Clin Pharmacol Toxicol | 2026

    Authors: Riise HS, Simpson M, Espnes KA, Tronvik EA, Husøy AK Observational study

    Candesartan is a medication used to prevent migraines. This research studied how different doses of candesartan affect migraine prevention. The study involved 166 adults, mostly women, with episodic or chronic…

  8. Preliminary evidence of long-term safety and effectiveness of anti-CGRP drugs for migraine prevention in people with comorbid epilepsy: A 52-week follow-up retrospective study.

    Epilepsia Open | 2026

    Authors: Romozzi M, Burgalassi A, Ceriello F, Martino P, Sette G Observational study

    This study looked at the safety and effectiveness of anti-CGRP drugs for migraine prevention in people with epilepsy. Researchers followed 11 female patients, aged around 35 years, over 52 weeks. These patients had…

  9. Comparative effectiveness and safety of topiramate versus amitriptyline for the prophylactic management of chronic migraine: a prospective comparative study.

    Front Pain Res (Lausanne) | 2026

    Authors: Karami MM, Hassan A, Alkhotani A, Basheikh M, Badahdah A Clinical trial

    Chronic migraine significantly affects people's lives and well-being. Topiramate and amitriptyline are two common medications for preventing migraines. This study compared their effectiveness and safety in treating…

  10. Cost-utility analysis of erenumab preventive treatment for chronic migraine in China.

    Front Public Health | 2026

    Authors: Wang L, Zhu M, Hu Q, Lou S, Wu M Other / unclear

    This study looked at the cost-effectiveness of erenumab for chronic migraine in China. Erenumab is a preventive treatment given as an injection every four weeks. Researchers compared its effects to no preventive…

  11. Guanfacine as a potential preventive therapy for chronic migraine: a mechanistic hypothesis.

    Front Neurol | 2026

    Authors: Kesayan T, Patel K Clinical trial

    Guanfacine is a medication that may help prevent chronic migraines. Many patients still struggle with migraines despite existing treatments. About one-third of chronic migraine patients do not find relief. Current…

  12. Persistence and Reasons for Treatment Discontinuation of Anti-CGRP Therapies in Migraine Prophylaxis: A Systematic Review and Meta-analysis of Real-World Studies.

    Pain Ther | 2026

    Authors: Pellesi L, Yangjeh A, Hajjaj I, Onan D, Waliszewska-Prosół M Systematic review / meta-analysis

    Anti-CGRP therapies are important for preventing migraines. This study looked at how long patients stay on these treatments. It also examined why some patients stop using them. Researchers gathered data from various…

  13. Therapeutic Applications of rTMS in Migraine Prophylaxis.

    J Integr Neurosci | 2026

    Authors: Siokas V, Marogianni C, Liampas I, Sokratous M, Tsirelis D Review

    Migraine is a significant cause of disability, especially for young adults. Many patients benefit from recent preventive therapies, but some still struggle with treatment. Repetitive Transcranial Magnetic Stimulation…

  14. OnabotulinumtoxinA Improves Sleep Quality in Patients with Chronic Migraine: A Prospective Real-World Study.

    Toxins (Basel) | 2026

    Authors: Viticchi G, Falsetti L, Bartolini M, Salvemini S, De Vanna G Observational study

    months of treatment. Researchers found that sleep quality improved significantly in patients after receiving OBT-A. Specifically, 63% of patients reported better sleep after three months. Patients also experienced…

  15. Early improvements in function with atogepant as assessed by the Activity Impairment in Migraine-Diary: Post hoc analyses of three randomized, phase 3 clinical trials of atogepant for the preventive treatment of migraine.

    Headache | 2026

    Authors: Lipton RB, Gandhi P, Gantenbein AR, Dabruzzo B, Carr K Clinical trial

    Atogepant is a new treatment for preventing migraines. This study looked at how it helps improve daily activities. Researchers analyzed data from three large clinical trials. They focused on patient-reported outcomes…

  16. Comparative Efficacy of Acupuncture, Pharmacological Interventions, Sham Acupuncture, and Placebo for Migraine Prevention: A Bayesian Network Meta-Analysis.

    Pain Res Manag | 2026

    Authors: Zhu Q, Wang Y, Yang X, Yang J, Song X Systematic review / meta-analysis

    This study looked at how well acupuncture, medications, sham acupuncture, and placebo work for preventing migraines. Researchers reviewed 32 randomized controlled trials to gather data. They focused on how these…

  17. Depressive and anxiety symptoms during CGRP-targeted migraine prevention: A systematic review and meta-analysis.

    Cephalalgia | 2026

    Authors: Al-Sayegh Z, Al-Khazali S, Al-Khazali HM, Christensen RH, Videbech P Systematic review / meta-analysis

    Migraine often occurs alongside depression and anxiety, worsening patients' overall health. This study looked at how CGRP-targeted therapies affect these mental health symptoms. CGRP-targeted treatments are effective…

  18. Effectiveness of Rimegepant for the Acute Treatment of Migraine Among Participants Using Different Types of Preventive Therapy: Analyses from CONFIDENCE.

    Neurol Ther | 2026

    Authors: Lipton RB, Goadsby PJ, Pozo-Rosich P, Urani A, Lambru G Observational study

    This study looked at how well rimegepant works for treating migraines. Researchers focused on patients using different preventive medications. The study involved participants in the United States who had 3-14…

  19. Candesartan for Migraine Prophylaxis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

    Clin Neuropharmacol | 2026

    Authors: Abdeldayem MR, Elsherbeeny A Systematic review / meta-analysis

    This study reviewed the effectiveness of candesartan for preventing migraines. Migraines are common and can severely impact daily life. Many patients struggle with current preventive treatments due to side effects or…

  20. Retrospective Review of Dual CGRP-Targeted Regimens for Acute and Preventive Treatment of Migraines in a Veteran Population.

    Fed Pract | 2026

    Authors: Forrest A, Billow D, Martin A Clinical trial

    A recent study examined the safety and effectiveness of dual CGRP-targeted treatments for migraines. Researchers focused on patients who used both preventive and acute CGRP medications. The study included 89…